SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,009.25 -70.71
( -0.09%)

Global Indices

Nasdaq

53,757.60 -103.39
(-0.19%)

Dow Jones

7,807.18 -12.81
(-0.16%)

Hang Seng

68,711.00 402.41
(0.59%)

Nikkei 225

10,753.31 -19.36
(-0.18%)

Forex

USD-INR

95.39 0.02
(0.02%)

EUR-INR

109.98 -0.03
(-0.03%)

GBP-INR

128.68 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

26.88

64553.14

EPS(TTM)

Face Value()

Div & Yield %

200.88

0.98

Back

infosys ltd

Urja Global consolidated net profit declines 14.00% in the June 2026 quarter

Aug 06,2026

Net profit of Urja Global declined 14.00% to Rs 0.43 crore in the quarter ended June 2026 as against Rs 0.50 crore during the previous quarter ended June 2025. Sales declined 26.56% to Rs 13.96 crore in the quarter ended June 2026 as against Rs 19.01 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	13.96	19.01	-27
OPM %	3.94	3.31	-
PBDT	0.54	1.09	-50
PBT	0.43	0.97	-56
NP	0.43	0.50	-14

78,009.25 -70.71 ( -0.09%)

53,757.60 -103.39 (-0.19%)

7,807.18 -12.81 (-0.16%)

68,711.00 402.41 (0.59%)

10,753.31 -19.36 (-0.18%)

95.39 0.02 (0.02%)

109.98 -0.03 (-0.03%)

128.68 -0.13 (-0.10%)

0.60 0.00 (-0.03%)